Xarelto Lawsuit
Serious Bleeding and Hemorrhage from Rivaroxaban
Xarelto (rivaroxaban) has been linked to uncontrolled bleeding and hemorrhage. If you've been harmed by Xarelto, you may have a legal claim.
What Is Xarelto?
Xarelto (rivaroxaban) is an anticoagulant medication manufactured by Johnson & Johnson and Bayer, approved for preventing blood clots and treating deep vein thrombosis.
It belongs to a class of drugs known as direct oral anticoagulants (DOACs).
Health Risks and Alleged Injuries
Lawsuits allege that Xarelto has caused uncontrolled bleeding, hemorrhage, gastrointestinal bleeding, and bleeding-related deaths. Some users report severe complications despite following dosing instructions.
Plaintiffs claim that manufacturers failed to adequately warn about bleeding risks and the lack of a reversal agent.
Litigation Status
Xarelto litigation has resulted in significant settlements. Thousands of lawsuits have been filed and resolved through MDL proceedings.
Many claimants have received substantial compensation for bleeding-related injuries and deaths.
Who May Qualify
Individuals who took Xarelto and subsequently experienced severe bleeding, hemorrhage, or related complications may qualify. Medical documentation of bleeding events is essential.
You must have used the medication and developed serious bleeding complications.
Next Steps
If you or a loved one took Xarelto and suffered serious bleeding complications or death, contact our firm for a free case review. We have experience with Xarelto claims.
Deadlines apply to filing claims, so prompt action is important.
Free Case Review
Learn if you have a claim for Xarelto-related injuries.
Start Your ReviewNo fees. No commitments. Confidential.
Key Facts
- Direct oral anticoagulant (DOAC)
- Manufactured by Johnson & Johnson and Bayer
- Linked to severe bleeding and hemorrhage
- Settled MDL with significant recoveries
The information on this page is for general informational purposes only and does not constitute legal advice.